Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment

by Snidow Jerry W, Wakeford John H, Williams Vanessa C, Olliffe Jeffrey F, Rodriguez Allan, DeJesus Edwin, Sension Michael G, Keiser Philip H, Shachoy-Clark Anne D, Fleming Julie W, Pakes Gary E, Hernandez Jaime E
Published 2005-01-01